Viewing Study NCT00849550


Ignite Creation Date: 2025-12-24 @ 5:06 PM
Ignite Modification Date: 2026-05-21 @ 5:34 AM
Study NCT ID: NCT00849550
Status: COMPLETED
Last Update Posted: 2012-12-24
First Post: 2009-02-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.
Sponsor: Herbert Hurwitz
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Unspecified Adult Solid Tumor, Protocol Specific View
None Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced Solid Tumors View
None Cancer View
None Capecitabine View
None XELOX View
None Neoplasms View
None Oxaliplatin View
None Bevacizumab View
None RAD001 View